Chronic Limb-Threatening Ischemia in Patients with Type 2 Diabetes: Revascularization Index as a Predictor for Primary Endovascular Intervention Outcome.
amputation
angioplasty
chronic limb-threatening ischemia
diabetes mellitus
revascularization index
Journal
Vascular health and risk management
ISSN: 1178-2048
Titre abrégé: Vasc Health Risk Manag
Pays: New Zealand
ID NLM: 101273479
Informations de publication
Date de publication:
2023
2023
Historique:
received:
04
11
2022
accepted:
21
06
2023
medline:
8
8
2023
pubmed:
7
8
2023
entrez:
7
8
2023
Statut:
epublish
Résumé
Chronic limb-threatening ischemia in patients with diabetes is associated with a high risk of adverse outcomes. The associated co-morbidities, the heterogeneity of foot presentation and the distribution of atherosclerotic lesions led to the emergence of multiple revascularization strategies and scoring systems to improve management outcomes. This study aimed to introduce a new index, the revascularization index (RI), and to assess its predictive value for the outcomes of primary endovascular intervention in patients with type 2 diabetes presenting with chronic limb-threatening ischemia. A retrospective electronic medical records review was conducted for patients with type 2 diabetes presenting with chronic limb-threatening ischemia managed at King Abdullah University Hospital by primary endovascular interventions between January 2014 and August 2019. The RI was analyzed for its predictive value for the treatment outcomes. A total of 187 patients were included in this study, with a major lower limb amputation rate of 19.3%. The performance of the RI was excellent in predicting secondary revascularization (AUC = 0.80, 95% CI: 0.73-0.86, The RI can be used to predict major adverse lower limb events (MALE). It might be used as a guide for the extent of endovascular interventions for diabetic chronic limb-threatening ischemia with multi-level outflow atherosclerotic disease.
Identifiants
pubmed: 37547281
doi: 10.2147/VHRM.S394521
pii: 394521
pmc: PMC10402884
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
495-504Informations de copyright
© 2023 Shatnawi et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
J Vasc Bras. 2020 May 08;19:e20190070
pubmed: 34178056
J Vasc Surg. 2013 Sep;58(3):814-26
pubmed: 23972249
Ann Vasc Surg. 2014 Oct;28(7):1729-36
pubmed: 24952297
Am J Med. 2004 Feb 15;116(4):236-40
pubmed: 14969651
Semin Intervent Radiol. 2014 Dec;31(4):378-88
pubmed: 25435665
Am Fam Physician. 2019 Mar 15;99(6):362-369
pubmed: 30874413
Atherosclerosis. 1981 Feb-Mar;38(3-4):339-46
pubmed: 7225173
Can J Cardiol. 2018 Apr;34(4):356-361
pubmed: 29571419
J Vasc Surg. 2013 Apr;57(4 Suppl):18S-26S
pubmed: 23522713
Circ Cardiovasc Interv. 2016 Feb;9(2):e001946
pubmed: 26858079
J Vasc Surg. 2013 Jan;57(1):44-9
pubmed: 23058724
Eur J Vasc Endovasc Surg. 2005 Jun;29(6):620-7
pubmed: 15878541
Exp Ther Med. 2018 Feb;15(2):1680-1685
pubmed: 29434753
Semin Vasc Surg. 2018 Jun - Dec;31(2-4):56-65
pubmed: 30876642
Int J Nephrol. 2016;2016:4870749
pubmed: 27529033
Br J Plast Surg. 1987 Mar;40(2):113-41
pubmed: 3567445
Cardiovasc Diabetol. 2020 Sep 26;19(1):151
pubmed: 32979922
Eur J Vasc Endovasc Surg. 2018 Apr;55(4):518-527
pubmed: 29402670
World J Diabetes. 2015 Jul 10;6(7):961-9
pubmed: 26185603
Plast Reconstr Surg. 2006 Jun;117(7 Suppl):261S-293S
pubmed: 16799395
Lancet Glob Health. 2019 Aug;7(8):e1020-e1030
pubmed: 31303293
N Engl J Med. 2022 Dec 22;387(25):2305-2316
pubmed: 36342173
J Vasc Surg. 2014 Jan;59(1):220-34.e1-2
pubmed: 24126108
Eur J Vasc Endovasc Surg. 2014 May;47(5):517-22
pubmed: 24491282
Circ Cardiovasc Interv. 2016 Feb;9(2):e002376
pubmed: 26861113
Rev Cardiovasc Med. 2004 Fall;5(4):189-93
pubmed: 15580157
Clin Chem. 2005 Oct;51(10):1893-5
pubmed: 16189381
Vasc Health Risk Manag. 2019 Jul 01;15:187-208
pubmed: 31308682
Int J Mol Sci. 2021 Feb 18;22(4):
pubmed: 33670461
Circulation. 2017 Mar 21;135(12):e686-e725
pubmed: 27840332
Adv Wound Care (New Rochelle). 2018 Jun 1;7(6):171-176
pubmed: 29892493
Vasc Health Risk Manag. 2018 Apr 26;14:63-74
pubmed: 29731636
JAMA. 2002 May 15;287(19):2570-81
pubmed: 12020339
Eur J Vasc Endovasc Surg. 2019 Jul;58(1):52-59
pubmed: 30786974
Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S1-S109.e33
pubmed: 31182334
JAMA. 2009 Jan 28;301(4):415-24
pubmed: 19176443
Arterioscler Thromb Vasc Biol. 2020 Aug;40(8):1808-1817
pubmed: 32580632
J Vasc Surg. 2017 Mar;65(3):695-704
pubmed: 28073665
Diabetes Care. 2010 May;33(5):977-82
pubmed: 20200304
Methodist Debakey Cardiovasc J. 2012 Oct-Dec;8(4):10-4
pubmed: 23342182
J Vasc Surg. 2007 Jan;45 Suppl S:S5-67
pubmed: 17223489
Eur J Vasc Endovasc Surg. 2018 Mar;55(3):305-368
pubmed: 28851596
J Am Coll Cardiol. 2006 Mar 7;47(5):921-9
pubmed: 16516072